The Alzheimer’s research community has been working for decades to find an effective treatment for Alzheimer’s disease, largely by targeting one of the hallmarks…
The progression of dementia is often unpredictable as people’s symptoms can ebb and flow. But, clinicians can distinguish the different stages of dementia, identifying…
Alzheimer’s is incredibly prevalent, but notoriously difficult to diagnose. Some of the most important information can only be gleaned from expensive and invasive processes,…
Dave Poritzky is the CEO of Envista Strategies, a boutique advisory and investment firm focusing on early-stage company growth and later-stage strategic challenges. He…
A new approach to Alzheimer’s — a pill containing a key feature of human cells called mitochondria — is being developed to treat the…
Most people in the late stages of dementia eventually lose the ability to feed themselves. Tube feeding — a tube inserted into the stomach…
There are a lot of unanswered questions about Alzheimer’s, but one thing the Alzheimer’s community knows well is that getting older is the disease’s…
Certain genes like ApoE that play an important role in the disease. ApoE’s genetic variant, known as ApoE4, is the strongest genetic risk factor…
The initial results from Eli Lilly and Co’s Phase 2 clinical trial for experimental Alzheimer’s drug donanemab provide much needed hope for the Alzheimer’s…
Despite more than a century of research since Alzheimer’s disease was first described in 1906, diagnosing Alzheimer’s remains extremely challenging for physicians. Researchers are…
“Can I look into your future and can I accurately estimate how much beta-amyloid you’re going to accumulate over the next two years, the…
Every week in the Being Patient weekly newsletter, founder Deborah Kan shares a thought with readers. This holiday, she reflects on what she is…
The pandemic has taken an enormous toll on caregivers who are staying home, figuring out ways to observe the holiday safely and looking after…
As part of our BrainTalk series, Being Patient spoke with Dr. Claudia Kawas, co-lead investigator of the 90+ Study, about the complex pathothologies of…
The first ever commercial Alzheimer’s blood test is on the market. It’s big progress. Some experts have reservations because it hasn’t yet secured FDA…